Royal Bank Of Canada Issues Positive Forecast for NorthWest Health Prop Real Est Inv Trust (TSE:NWH.UN) Stock Price

NorthWest Health Prop Real Est Inv Trust (TSE:NWH.UNGet Free Report) had its price target lifted by Royal Bank Of Canada from C$5.50 to C$6.00 in a research note issued to investors on Wednesday,BayStreet.CA reports. The firm currently has a “sector perform” rating on the stock. Royal Bank Of Canada’s target price indicates a potential upside of 1.52% from the company’s current price.

Several other brokerages have also weighed in on NWH.UN. Scotiabank increased their target price on NorthWest Health Prop Real Est Inv Trust from C$6.50 to C$7.00 in a research report on Thursday, November 13th. BMO Capital Markets increased their target price on shares of NorthWest Health Prop Real Est Inv Trust from C$5.00 to C$6.00 in a research report on Thursday, November 13th. Canadian Imperial Bank of Commerce upped their target price on NorthWest Health Prop Real Est Inv Trust from C$5.50 to C$5.75 in a research report on Thursday, November 13th. Finally, ATB Cormark Capital Markets downgraded NorthWest Health Prop Real Est Inv Trust from an “outperform” rating to a “sector perform” rating and set a C$6.25 price objective on the stock. in a research note on Friday, February 27th. One equities research analyst has rated the stock with a Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat.com, NorthWest Health Prop Real Est Inv Trust presently has a consensus rating of “Hold” and an average price target of C$6.13.

View Our Latest Stock Report on NorthWest Health Prop Real Est Inv Trust

NorthWest Health Prop Real Est Inv Trust Trading Up 1.5%

NWH.UN traded up C$0.09 during midday trading on Wednesday, hitting C$5.91. The company’s stock had a trading volume of 325,586 shares, compared to its average volume of 727,603. The company has a current ratio of 0.25, a quick ratio of 0.06 and a debt-to-equity ratio of 129.42. The firm has a market cap of C$1.47 billion, a P/E ratio of 29.24, a PEG ratio of 0.74 and a beta of 1.78. The firm has a 50-day moving average price of C$5.61 and a two-hundred day moving average price of C$5.30. NorthWest Health Prop Real Est Inv Trust has a 52-week low of C$4.44 and a 52-week high of C$6.07.

NorthWest Health Prop Real Est Inv Trust (TSE:NWH.UNGet Free Report) last announced its earnings results on Tuesday, February 24th. The company reported C($0.16) EPS for the quarter. NorthWest Health Prop Real Est Inv Trust had a negative net margin of 75.29% and a negative return on equity of 14.67%. The company had revenue of C$102.27 million for the quarter. On average, research analysts anticipate that NorthWest Health Prop Real Est Inv Trust will post 0.4905498 earnings per share for the current year.

NorthWest Health Prop Real Est Inv Trust Company Profile

(Get Free Report)

Northwest Healthcare Properties Real Estate Investment Trust provides investors with access to a portfolio of high-quality healthcare real estate. The company provides investors exposure to a well-diversified portfolio of healthcare real estate located in the greater areas of cities such as Australasia, Brazil, Germany, and Canada of which Australasia derives a majority of revenue to the company.

Featured Articles

Receive News & Ratings for NorthWest Health Prop Real Est Inv Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NorthWest Health Prop Real Est Inv Trust and related companies with MarketBeat.com's FREE daily email newsletter.